Clin Oncol | Volume 5, Issue 1 | Case Series | Open Access

The Role of Surgery in Small Cell Lung CarcinomaLimited Disease

Nídia Caires1*, Ana Rita Costa2, Rita Carvalho3, Vânia Caldeira1, João Santos Silva2, Dionísio Maia1, João Eurico Reis2, Sara Alfarroba1, Rita Barata2, Eugénia Pinto3 and Paulo Calvinho2

1Department of Pulmonology, Hospital de Santa Marta, Centro Hospitalar Universitário de Lisboa Central, Portugal 2Department of Thoracic Surgery, Hospital de Santa Marta, Centro Hospitalar Universitário de Lisboa Central, Portugal 3Department of Pathology, Hospital São José, Centro Hospitalar Universitário de Lisboa Central, Portugal

*Correspondance to: NĂ­dia Caires 

Fulltext PDF

Abstract

Small cell lung carcinoma represents about 10% to 15% of all lung cancers. It exhibits an aggressive behavior and potential for early distant metastasis. Systemic chemotherapy with or without radiotherapy are the cornerstones of treatment in most patients with small cell lung carcinoma. However, in cases of limited stage disease and in selected patients, pulmonary resection surgery may be an option. In this study, we present three cases of small cell lung carcinoma that underwent pulmonary resection surgery in 2019, 2017 and 2015, respectively. At the time of writing, none of these patients presented recurrence of the disease.

Keywords:

Surgery; Limited disease; Small cell lung carcinoma

Citation:

Caires N, Costa AR, Carvalho R, Caldeira V, Silva JS, Maia D. The Role of Surgery in Small Cell Lung Carcinoma-Limited Disease. Clin Oncol. 2020; 5: 1686.

Subscribe to Our Newsletter